EyePoint Pharmaceuticals
EYPT
#6195
Rank
A$1.46 B
Marketcap
A$17.46
Share price
-2.25%
Change (1 day)
9.31%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -A$0.41 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are A$7.61 Million. In 2025 the company made an earning of -A$0.34 Billion a decrease over its 2024 earnings that were of -A$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.41 Billion21.15%
2025 -A$0.34 Billion63.24%
2024 -A$0.21 Billion104.29%
2023 -A$99.48 Million-29.88%
2022 -A$0.15 Billion87.2%
2021 -A$75.79 Million38.58%
2020 -A$54.69 Million-24.56%
2019 -A$72.49 Million
2017 -A$33.07 Million22.59%
2016 -A$26.97 Million-8.02%
2015 -A$29.32 Million-296.09%
2014 A$14.95 M-174.02%
2013 -A$20.2 Million37.42%
2012 -A$14.7 Million-56.29%
2011 -A$33.63 Million-1062.38%
2010 A$3.49 M-250.43%
2009 -A$2.33 Million-89.5%
2008 -A$22.13 Million
2005 -A$13.65 Million56.99%
2004 -A$8.7 Million73.7%
2003 -A$5.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-A$3.1 Million-99.20% Bahamas
NRC Health
NRC
A$28.09 M-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA